echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Imaging of massive intrahepatic single-tube cell carcinoma

    Imaging of massive intrahepatic single-tube cell carcinoma

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     

     

     

     

    【Abstract】Intrahepatic cholangiocarcinoma (ICC) originates from intrahepatic bile duct epithelial cells, second only to the incidence of hepatocellular carcinoma, and ranks second in liver malignancies
    .


    Radical resection is still the only possible method before treatment.


    【Abstract】Intrahepatic cholangiocarcinoma (ICC) originates from intrahepatic bile duct epithelial cells, second only to the incidence of hepatocellular carcinoma, and ranks second in liver malignancies


     

    For inoperable patients, adjuvant therapy, liver transplantation, ablation therapy, and targeted immunotherapy can be used to prolong the survival time of patients.
    Therefore, radical resection and palliative treatment are of vital importance for the treatment of intrahepatic cholangiocarcinoma
    .

    For inoperable patients, adjuvant therapy, liver transplantation, ablation therapy, and targeted immunotherapy can be used to prolong the survival time of patients.
    Therefore, radical resection and palliative treatment are of vital importance for the treatment of intrahepatic cholangiocarcinoma
    .


     

     

     

     

     

    To sum up, intrahepatic cholangiocarcinoma is a type with high malignancy, difficult treatment and poor prognosis
    .

    To sum up, intrahepatic cholangiocarcinoma is a type with high malignancy, difficult treatment and poor prognosis
    .


    To sum up, intrahepatic cholangiocarcinoma is a type with high malignancy, difficult treatment and poor prognosis



     

     

     

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.